Final Program for the ATS International Conference Is Available in Printed and Digital Format
Total Page:16
File Type:pdf, Size:1020Kb
WELCOME TO ATS 2017 • WASHINGTON, DC Welcome to ATS 2017 Welcome to Washington, DC for the 2017 American Thoracic Society International Conference. The conference, which is expected to draw more than 15,000 investigators, educators, and clinicians, is truly the destination for pediatric and adult pulmonary, critical care, and sleep medicine professionals at every level of their careers. The conference is all about learning, networking and connections. Because it engages attendees across many disciplines and continents, the ATS International Conference draws a large, diverse group of participants, a dedicated and collegial community that inspires each of us to make a difference in patients’ lives, now and in the future. By virtue of its size — ATS 2017 features approximately 6,700 original research projects and case reports, 500 sessions, and 800 speakers — participants can attend David Gozal, MD sessions and special events from early morning to the evening. At ATS 2017 there will be something for President everyone. American Thoracic Society Don’t miss the following important events: • Opening Ceremony featuring a keynote presentation by Nobel Laureate James Heckman, PhD, MA, from the Center for the Economics of Human Development at the University of Chicago. • Ninth Annual ATS Foundation Research Program Benefit honoring David M. Center, MD, with the Foundation’s Breathing for Life Award on Saturday. • ATS Diversity Forum will feature Eliseo J. Pérez-Stable, MD, Director, National Institute on Minority Health and Health Disparities at the National Institutes of Health. • Keynote Series highlight state of the art lectures on selected topics in an unopposed format to showcase major discoveries in pulmonary, critical care and sleep medicine. • Respiratory Health Awards, which includes the Trudeau Medal, Distinguished Achievement Awards, and Amberson Lecture, given by Peter D. Pare, MD, of the University of British Columbia. • ATS Plenary Session will feature a talk by Marc L. Busch, PhD, the Karl F. Landegger Professor of International Business Diplomacy at the School of Foreign Service, Georgetown University. Zea Borok, MD • Assembly Membership Meetings, which are open to all attendees. Chair International Conference These events create a sense of community among the International Conference attendees, which is Committee precisely what our founders had hoped when they established the world’s first respiratory society. Finally, we wish to acknowledge the hard work and outstanding efforts of the members of the International Conference Committee, Education Committee, Assembly Program Committees, and ATS staff. The success of our conference depends on the dedication, creativity, and support of these individuals. We welcome you to the International Conference and hope you take advantage of all Washington has to offer. INTERNATIONAL CONFERENCE COMMITTEE Zea Borok, MD, Chair 2015-2017 Anastassios C. Koumbourlis, MD, MPH Karen M. Ridge, PhD Jess Mandel, MD, Chair 2017-2019 Tim Lahm, MD Jussi J. Saukkonen, MD JiYeon Choi, PhD, RN Patty Lee, MD Frank C. Sciurba, MD Colin R. Cooke, MD Tricia D. LeVan, PhD Gwen S. Skloot, MD Sonye K. Danoff, MD, PhD Augusto A. Litonjua, MD Christopher G. Slatore, MD Laura C. Feemster, MSc, MD William Man, MD, PhD Anne I. Sperling, PhD Andrew P. Fontenot, MD Mark L. Metersky, MD Renee D. Stapleton, MD, PhD Michelle N. Gong, MS, MD Paul E. Moore, MD Lynn T. Tanoue, MD David Gozal, MD, MBA Marc Moss, MD Esra Tasali, MD Tillie-Louise Hackett, BS(Hons), PhD Marilyn Moy, MD, MSc Judith Tate, PhD, RN Anna Hemnes, MD Robert L. Owens, MD Atul Malhotra, MD ATS 2017 • Washington, DC TABLE OF CONTENTS ATS 2017 INTERNATIONAL CONFERENCE MAY 19-24 WASHINGTON, D.C. This year the session portion of the Final Program for the ATS International Conference is available in printed and digital format. This publication contains the programs and speakers for the postgraduate courses, scientific and educational sessions presented at the conference. You can download this PDF, the Conference APP or access the program via the online program itinerary. 1 Friday Postgraduate Courses 10 Saturday Postgraduate Courses 21 Sunday Conference Sessions 129 Monday Conference Sessions 246 Tuesday Conference Sessions 356 Wednesday Conference Sessions The information contained in this program is up to date as of March 9, 2017. For the most current session information, please visit the online program itinerary. CONFERENCE PLANNERS DISCLOSURES In accordance with the ACCME Standards for Commercial Support, and those of the ATS Policy on Management of Conflict of Interest in Official ATS Documents, Projects and Conferences, ATS Policy Governing Relationships Between the Tobacco Industry, ATS Members, and Non-Members Who Participate in ATS Activities, and ATS Policy on Professionalism and Ethical Conduct chairs, moderators, presenters and official planners of the International Conference are required to disclose to ATS any potential conflicts of interest (COI) held by them or their spouse/life partner relevant to their presentation(s) or conference role, including all professional or other financial involvement with tobacco or e-cigarette entities, all relevant financial relationships with commercial interests, and all other relationships that could be perceived as influencing their participation. Conference presenters are also asked to disclose if there will be any discussion in the presentation of “off-label” (unapproved) use of substances/products not approved in the United States for the use under discussion (as per the U.S. Food and Drug Administration Guidance for Industry: Industry-Supported Scientific and Educational Activities). For the 2017 International Conference, this disclosure information for all individuals in control of content was requested and received by ATS in advance of the Conference, reviewed by appropriate ATS reviewers, and session chairs and others in positions of authority were instructed to manage (resolve) identified faculty conflicts according to procedures overseen by the ATS Ethics and Conflict of Interest Committee. To access the disclosures made by the faculty of the 2017 International Conference, please go to http://conference.thoracic.org/speakers The following members of the Education Committee have disclosed no financial relationships with commercial interests: Debra M. Boyer, MD, Chair DorAnne M. Donesky, PhD, ANP-BC Abagail R. Lara, MD Viswam S. Nair, MSCR, MD Jason T. Poston, MD, Vice Chair Garth Garrison, MD Moishe Liberman, MD, PhD Jeremy E. Orr, MD Gaetane C. Michaud, MD, Vice Chair David Gozal, MD, MBA Andrew Luks, MD Susan Pasnick, MD Mark K. Abe, MD Margaret M. Hayes, MD Patrick Lyons, MD Jessica E. Pittman, MD, MPH Shozab Ahmed, MBBS Amjad Horani, MD Samir Makani, MD Allan J. Walkey, MD, MSc William G. Carlos, MD Shazia M. Jamil, MD Atul Malhotra, MD Tisha S. Wang, MD Alison S. Clay, MD Carl A. Kaplan, MD Jakob I. McSparron, MD Carolyn H. Welsh, MD Walter D. Conwell, MD Jack Kelly Paul E. Moore, MD Lisa F. Wolfe, MD Daniel R. Crouch, MD, MS Denay P. Kirkpatrick, DNP Marc Moss, MD The following members of the Education Committee have disclosed the following financial relationships with commercial interests: Caralee E. Caplan-Shaw, MD: AristaMD Colleen L. Channick, MD: Actelion Samaan Rafeq, MD: Boston Scientific Mary E. Strek, MD: Boehringer and Cohero Health (Consultant); Bard Pharmaceuticals US and Bayer (Consultant, Speaker); Veran Medical Ingelheim Pharmaceuticals (Data Peripheral Vascular, Inc. and Veran HealthCare Pharmaceuticals (Spouse- (Consultant) and Safety Monitoring Board, Medical Technologies (Food/Beverage Consultant); Medtronic and Olympus Research Support); Gilead Sciences, Jordan S. Rettig: Boston’s Children Only); Cook Incorporated (Food/ Corporation of the Americas (Consultant) InterMune, MedImmune, and Vertex Hospital (Intellectual Property Not Beverage Only, Spouse-CME Speaker); Pharmaceuticals (research support) Charles Dela Cruz, MD, PhD: Cempra Commercialized) MedImmune, Novartis Pharma and (Advisory Committee); Sanofi-Aventis Bishoy Zakhary, MD: ELSO ECMO Training Teva Pharmaceuticals USA (Research U.S. (Consultant) Courses and ACCP (Course Instructor) Support); Myriad Genetic Laboratories (Spouse-Consultant) The following members of the International Conference Committee have disclosed no financial relationships with commercial interests: Zea Borok, MD, Chair Michelle N. Gong, MD, MS William Man, MD, PhD Gwen S. Skloot, MD Jess Mandel, MD, Chair Appointee David Gozal, MD, MBA Paul E. Moore, MD Christopher G. Slatore, MD JiYeon Choi, PhD, RN Tillie-Louise Hackett, PhD Marc Moss, MD Anne I. Sperling, PhD Colin R. Cooke, MD Anastassios C. Koumbourlis, MD, MPH Marilyn Moy, MD, MSc Renee D. Stapleton, PhD, MD Sonye K. Danoff, MD, PhD Patty Lee, MD Robert L. Owens, MD Lynn T. Tanoue, MD Laura C. Feemster, MSc, MD Tricia D. LeVan, PhD Karen M. Ridge, PhD Esra Tasali, MD Andrew P. Fontenot, MD Atul Malhotra, MD Jussi J. Saukkonen, MD Judith Tate, PhD, RN The following members of the International Conference Committee have disclosed the following financial relationships with commercial interests: Anna Hemnes, MD: Actelion Tim Lahm, MD: Bayer HealthCare Mark L. Metersky, MD: Aradigm and Bayer Pharmaceuticals, US and United Pharmaceuticals (Speaker); Gilead (Research Support); EBSCO (Consultant); Therapeutics Corporation (Advisory Sciences and Pfizer AG (Research Grifols (Advisory Committee) Committee); Pfizer, Inc. (Expert Support) Frank C. Sciurba, MD: Boehringer Testimony) Augusto